These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

644 related items for PubMed ID: 15005850

  • 1. Teriparatide [PTH(1-34)] strengthens the proximal femur of ovariectomized nonhuman primates despite increasing porosity.
    Sato M, Westmore M, Ma YL, Schmidt A, Zeng QQ, Glass EV, Vahle J, Brommage R, Jerome CP, Turner CH.
    J Bone Miner Res; 2004 Apr; 19(4):623-9. PubMed ID: 15005850
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Interrelationships between bone microarchitecture and strength in ovariectomized monkeys treated with teriparatide.
    Chen P, Jerome CP, Burr DB, Turner CH, Ma YL, Rana A, Sato M.
    J Bone Miner Res; 2007 Jun; 22(6):841-8. PubMed ID: 17352652
    [Abstract] [Full Text] [Related]

  • 4. Treatment of skeletally mature ovariectomized rhesus monkeys with PTH(1-84) for 16 months increases bone formation and density and improves trabecular architecture and biomechanical properties at the lumbar spine.
    Fox J, Miller MA, Newman MK, Turner CH, Recker RR, Smith SY.
    J Bone Miner Res; 2007 Feb; 22(2):260-73. PubMed ID: 17087625
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Biosynthetic human parathyroid hormone (1-34) effects on bone quality in aged ovariectomized rats.
    Sato M, Zeng GQ, Turner CH.
    Endocrinology; 1997 Oct; 138(10):4330-7. PubMed ID: 9322947
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Treatment with human parathyroid hormone (1-34) for 18 months increases cancellous bone volume and improves trabecular architecture in ovariectomized cynomolgus monkeys (Macaca fascicularis).
    Jerome CP, Burr DB, Van Bibber T, Hock JM, Brommage R.
    Bone; 2001 Feb; 28(2):150-9. PubMed ID: 11182372
    [Abstract] [Full Text] [Related]

  • 9. Effects of treatment of ovariectomized adult rhesus monkeys with parathyroid hormone 1-84 for 16 months on trabecular and cortical bone structure and biomechanical properties of the proximal femur.
    Fox J, Miller MA, Recker RR, Turner CH, Smith SY.
    Calcif Tissue Int; 2007 Jul; 81(1):53-63. PubMed ID: 17551766
    [Abstract] [Full Text] [Related]

  • 10. New bone formation with teriparatide [human parathyroid hormone-(1-34)] is not retarded by long-term pretreatment with alendronate, estrogen, or raloxifene in ovariectomized rats.
    Ma YL, Bryant HU, Zeng Q, Schmidt A, Hoover J, Cole HW, Yao W, Jee WS, Sato M.
    Endocrinology; 2003 May; 144(5):2008-15. PubMed ID: 12697709
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of single and concurrent intermittent administration of human PTH (1-34) and incadronate on cancellous and cortical bone of femoral neck in ovariectomized rats.
    Zhang L, Endo N, Yamamoto N, Tanizawa T, Takahashi HE.
    Tohoku J Exp Med; 1998 Oct; 186(2):131-41. PubMed ID: 10223616
    [Abstract] [Full Text] [Related]

  • 13. Combined treatment with PTH (1-34) and OPG increases bone volume and uniformity of mineralization in aged ovariectomized rats.
    Valenta A, Roschger P, Fratzl-Zelman N, Kostenuik PJ, Dunstan CR, Fratzl P, Klaushofer K.
    Bone; 2005 Jul; 37(1):87-95. PubMed ID: 15869920
    [Abstract] [Full Text] [Related]

  • 14. Lack of bone neoplasms and persistence of bone efficacy in cynomolgus macaques after long-term treatment with teriparatide [rhPTH(1-34)].
    Vahle JL, Zuehlke U, Schmidt A, Westmore M, Chen P, Sato M.
    J Bone Miner Res; 2008 Dec; 23(12):2033-9. PubMed ID: 18684088
    [Abstract] [Full Text] [Related]

  • 15. Abaloparatide, a novel PTH receptor agonist, increased bone mass and strength in ovariectomized cynomolgus monkeys by increasing bone formation without increasing bone resorption.
    Doyle N, Varela A, Haile S, Guldberg R, Kostenuik PJ, Ominsky MS, Smith SY, Hattersley G.
    Osteoporos Int; 2018 Mar; 29(3):685-697. PubMed ID: 29260289
    [Abstract] [Full Text] [Related]

  • 16. Six Weeks of Daily Abaloparatide Treatment Increased Vertebral and Femoral Bone Mineral Density, Microarchitecture and Strength in Ovariectomized Osteopenic Rats.
    Bahar H, Gallacher K, Downall J, Nelson CA, Shomali M, Hattersley G.
    Calcif Tissue Int; 2016 Nov; 99(5):489-499. PubMed ID: 27395059
    [Abstract] [Full Text] [Related]

  • 17. Intraosseous injection of rhBMP-2/calcium phosphate matrix improves bone structure and strength in the proximal aspect of the femur in chronic ovariectomized nonhuman primates.
    Seeherman HJ, Li XJ, Smith E, Parkington J, Li R, Wozney JM.
    J Bone Joint Surg Am; 2013 Jan 02; 95(1):36-47. PubMed ID: 23283371
    [Abstract] [Full Text] [Related]

  • 18. Bone anabolic effects of separate and combined therapy with growth hormone and parathyroid hormone on femoral neck in aged ovariectomized osteopenic rats.
    Wang L, Orhii PB, Banu J, Kalu DN.
    Mech Ageing Dev; 2001 Jan 02; 122(1):89-104. PubMed ID: 11163626
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Decreased bone remodeling and porosity are associated with improved bone strength in ovariectomized cynomolgus monkeys treated with denosumab, a fully human RANKL antibody.
    Kostenuik PJ, Smith SY, Jolette J, Schroeder J, Pyrah I, Ominsky MS.
    Bone; 2011 Aug 02; 49(2):151-61. PubMed ID: 21457806
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.